+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Liquid Biopsy Market: Analysis By Biomarkers (C-Tumor Cells, C-Tumor DNA, Vesicles), Cancer Type, By Product (Instruments, Reagents), By Region, By Country (2019 Edition): Opportunities and Forecast (2017-2024)

  • ID: 4850767
  • Report
  • October 2019
  • Region: Global
  • 200 pages
  • Azoth Analytics
1 of 3

FEATURED COMPANIES

  • Guardant Health
  • Qiagen
  • Roche Diagnostics
  • Thermo Fisher Scientific
  • MORE
Executive Summary

According to this research report, the Liquid Biopsy was valued at USD 899.55 million for the year 2018.

Over the recent years, Liquid Biopsy has been witnessing considerable growth on the back of growing focus on immunotherapy to cure cancer and shifting trend towards precision medicine along with high per capita healthcare expenditure and rapid adoption of novel diagnostic test by oncologist. Further, rising awareness for the early detection of cancer and sharp rise in its incidences have contributed to the growth rate of Liquid Biopsy Market.

Among the Circulating Biomarker, Ct- DNA is the most used biomarker for the diagnosis in pre and post cancerous stage, as it provides more comprehensive overview of the tumor genomic status. Ongoing research and clinical trials suggest that exosomes and nucleosomes, will provide more efficient diagnostic results and hence market will be growing in the forecast period.

In the forecast period, continuous research and development by private manufacturers, government organizations and designated government labs along with growing number of clinical trials in liquid biopsy is anticipated to provide momentum to the market growth. However, generation of revenue from the liquid biopsy is dependent upon the interest of third party payers, hindering the market growth.

Scope of the Report

Global Liquid Biopsy Market (Actual Period: 2017-2018, Forecast Period: 2019-2024)
  • Liquid Biopsy Market: Size, Growth, Forecast
  • Analysis By Cancer Type: Lung, Breast, Colorectal, Prostate, Others
  • Analysis By Circulating Biomarker: CTC, ct-DNA, Vesicles
  • Analysis By Product Type: Reagents, Instruments
Regional Liquid Biopsy Markets - North America, Europe, APAC, ROW (Actual Period: 2017-2018, Forecast Period: 2019-2024)
  • Liquid Biopsy Market: Size, Growth, Forecast
  • Analysis By Cancer Type: Lung, Breast, Colorectal, Prostate, Others
  • Analysis By Circulating Biomarker: CTC, ct-DNA, Vesicles
  • Analysis By Product Type: Reagents, Instruments
Country Analysis – U.S., Germany, France, Japan (Actual Period: 2017-2018, Forecast Period: 2019-2024)
  • Liquid Biopsy Market: Size, Growth, Forecast
  • Analysis By Cancer Type: Lung, Breast, Colorectal, Prostate, Others
  • Analysis By Circulating Biomarker: CTC, ct-DNA, Vesicles
  • Analysis By Product Type: Reagents, Instruments
Other Report Highlights
  • Competitive Landscape
  • Leading Companies
  • Investment and Partnerships
  • Product Analysis
  • Market Dynamics – Drivers and Restraints.
  • Market Trends
  • Porter Five Forces Analysis.
  • SWOT Analysis.
  • Company Analysis – Roche Diagnostics, Thermo Fisher Scientific, Guardant Health, Qiagen.
Customization of the Report
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Guardant Health
  • Qiagen
  • Roche Diagnostics
  • Thermo Fisher Scientific
  • MORE
1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Liquid Biopsy Market: Product Outlook

5. Global Liquid Biopsy Market: Growth and Forecast (2017-2024)

6. Global Liquid Biopsy Market: Segment Analysis
6.1 Global Liquid Biopsy Market Size, By Cancer Type: Breakdown (%)
6.2 Global Lung Cancer Liquid Biopsy Market, By Value (2017-2024)
6.3 Global Breast Cancer Liquid Biopsy Market, By Value (2017-2024)
6.4 Global Colorectal Cancer Liquid Biopsy Market, By Value (2017-2024)
6.5 Global Prostate Cancer Liquid Biopsy Market, By Value (2017-2024)
6.6 Global Others Liquid Biopsy Market, By Value (2017-2024)
6.7 Market attractiveness of Global Liquid Biopsy Market- By Cancer Type
6.8 Global Liquid Biopsy Market Size, By Circulating Biomarker: Breakdown (%)
6.9 Global CTC Liquid Biopsy Market, By Value (2017-2024)
6.10 Global ct-DNA Liquid Biopsy Market, By Value (2017-2024)
6.11 Global Vesicle Liquid Biopsy Market, By Value (2017-2024)
6.12 Market attractiveness of Global Liquid Biopsy Market- By Circulating Biomarker
6.13 Global Liquid Biopsy Market Size, By Product Type: Breakdown (%)
6.14 Global Reagent Liquid Biopsy Market, By Value (2017-2024)
6.15 Global Instrument Liquid Biopsy Market, By Value (2017-2024)

7. Global Liquid Biopsy Market: Regional Analysis
7.1 Global Liquid Biopsy Market Size, By Region : Breakdown (%)
7.1.1 Global Liquid Biopsy Market Size, By Region, 2024 (%)
7.2 North America Liquid Biopsy Market: Growth and Forecast
7.2.1 By Value (2017-2024)
7.2.2 By Cancer Type, By Value (2017-2024)
7.2.3 By Circulating Biomarker, By Value (2017-2024)
7.2.4 By Product Type, By Value (2017-2024)
7.3 North America Liquid Biopsy Market: Country Analysis (U.S)
7.3.1 U.S Liquid Biopsy Market, By Value (2017-2024)
7.3.2 U.S Liquid Biopsy Market, By Cancer Type, By Value (2017-2024)
7.3.3 U.S Liquid Biopsy Market, By Circulating Biomarker, By Value (2017-2024)
7.3.4 U.S Liquid Biopsy Market, By Product Type, By Value (2017-2024)
7.4 Europe Liquid Biopsy Market: Growth and Forecast
7.4.1 By Value (2017-2024)
7.4.2 By Cancer Type, By Value (2017-2024)
7.4.3 By Circulating Biomarker, By Value (2017-2024)
7.4.4 By Product Type, By Value (2017-2024)
7.5 Europe Liquid Biopsy Market: Country Analysis (Germany, France)
7.5.1 Germany Liquid Biopsy Market, By Value (2017-2024)
7.5.2 Germany Liquid Biopsy Market, By Cancer Type, By Value (2017-2024)
7.5.3 Germany Liquid Biopsy Market, By Circulating Biomarker, By Value (2017-2024)
7.5.4 Germany Liquid Biopsy Market, By Product Type, By Value (2017-2024)
7.5.5 France Liquid Biopsy Market, By Value (2017-2024)
7.5.6 France Liquid Biopsy Market, By Cancer Type, By Value (2017-2024)
7.5.7 France Liquid Biopsy Market, By Circulating Biomarker, By Value (2017-2024)
7.5.8 France Liquid Biopsy Market, By Product Type, By Value (2017-2024)
7.6 APAC Liquid Biopsy Market: Growth and Forecast
7.6.1 By Value (2017-2024)
7.6.2 By Cancer Type, By Value (2017-2024)
7.6.3 By Circulating Biomarker, By Value (2017-2024)
7.6.4 By Product Type, By Value (2017-2024)
7.7 APAC Liquid Biopsy Market: Country Analysis (Japan)
7.7.1 Japan Liquid Biopsy Market, By Value (2017-2024)
7.7.2 Japan Liquid Biopsy Market, By Cancer Type, By Value (2017-2024)
7.7.3 Japan Liquid Biopsy Market, By Circulating Biomarker, By Value (2017-2024)
7.7.4 Japan Liquid Biopsy Market, By Product Type, By Value (2017-2024)
7.8 ROW Liquid Biopsy Market: Growth and Forecast
7.8.1 By Value (2017-2024)
7.8.2 By Cancer Type, By Value (2017-2024)
7.8.3 By Circulating Biomarker, By Value (2017-2024)
7.8.4 By Product Type, By Value (2017-2024)

8. Global Liquid Biopsy Market: Competitive Landscape
8.1 Market share of Leading Global Companies
8.2 Global Liquid Biopsy Market : Investments and Partnerships
8.3 Global Liquid Biopsy Market: Product Analysis

9. Global Liquid Biopsy Market Dynamics
9.1 Global Liquid Biopsy Market Drivers
9.1.1 Rising incidence of cancer
9.1.2 Growing focus on immunotherapy to cure cancer
9.1.3 Growing government expenditure in cancer research
9.2 Global Liquid Biopsy Market Restraints
9.2.1 Technology is dependent upon the interest shown by third party payers
9.3 Global Liquid Biopsy Market Trend
9.3.1 Adoption of precision medicine for curing cancer
9.3.2 Early detection of cancer

10. Porter's Five Forces Analysis

11. SWOT Analysis

12. Policy and Regulatory Landscape

13. Company Profiles
13.1 Guardant Health
13.2 Roche Diagnostics
13.3 Thermo Fisher Scientific
13.4 Qiagen
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Roche Diagnostics
  • Thermo Fisher Scientific
  • Guardant Health
  • Qiagen
Note: Product cover images may vary from those shown
Adroll
adroll